Domov › Rakovina prostaty › Pennsylvania › Pittsburgh
Klinické štúdie Rakovina prostaty v meste Pittsburgh, PA
23 štúdií pre Rakovina prostaty hľadá účastníkov v zariadeniach v meste Pittsburgh a okolí (do cca 30 míľ). Otvorte štúdiu a zistite, kto sa môže zapojiť a ako kontaktovať tím.
Oficiálny text štúdie (anglicky)
Hľadáte účastníkov do štúdie? Zvýraznite ju na začiatku tejto stránky – $99 na 30 dní →
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Prebieha náborFáza 1/2
- University of Pittsburgh Medical Center, Pittsburgh
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
Prebieha náborFáza 3
- Allegheny General Hospital, Pittsburgh
- West Penn Hospital, Pittsburgh
- Jefferson Hospital, Jefferson Hills · 11 míľ odtiaľ
- a 3 ďalších
Distance-Based Exercise to Preserve Function and Prevent Disability
Prebieha nábor
- UPMC Hillman Cancer Center, Pittsburgh
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
Prebieha náborFáza 2
- UPMC Hillman Cancer Center, Pittsburgh
- UPMC-Passavant Hospital, Pittsburgh
- UPMC-Saint Clair Hospital Cancer Center, Pittsburgh
- a 2 ďalších
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
Prebieha náborFáza 1
- University of Pittsburgh Medical Center, Pittsburgh
A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
Prebieha náborFáza 3
- University of Pittsburgh Medical Center, Pittsburgh
A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation
Prebieha náborFáza 3
- Research Site, Pittsburgh
Trial of Xaluritamig in Adults With Metastatic Castration-resistant Prostate Cancer
Prebieha náborFáza 1
- University of Pittsburgh Medical Center Hillman Cancer Center, Pittsburgh
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Prebieha náborFáza 3
- UPMC-Magee Womens Hospital, Pittsburgh
- UPMC-Saint Margaret, Pittsburgh
- University of Pittsburgh Cancer Institute (UPCI), Pittsburgh
- a 6 ďalších
AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)
Prebieha náborFáza 3
- Research Site, Pittsburgh
Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer
Prebieha náborFáza 1
- University of Pittsburgh Medical Center, Pittsburgh
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
Prebieha náborFáza 3
- UPMC-Magee Womens Hospital, Pittsburgh
- UPMC-Saint Margaret, Pittsburgh
- UPMC Hillman Cancer Center, Pittsburgh
- a 9 ďalších
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Prebieha náborFáza 1/2
- University of Pittsburgh Medical Center, Hillman Cancer Center, Pittsburgh
Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
Prebieha náborFáza 1
- UPMC Hillman Cancer Center, Pittsburgh
Study Evaluating the Safety, Tolerability, and Efficacy of Xaluritamig in Combination With Androgen Receptor Pathway Inhibitors in Participants With Metastatic Hormone-sensitive Prostate Cancer
Prebieha náborFáza 1
- University of Pittsburgh Medical Center Hillman Cancer Center, Pittsburgh
Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors
Prebieha náborFáza 1
- University of Pittsburg Medical Center (UPCM), Pittsburgh
Study of CX-5461 in Patients With Solid Tumours and BRCA1/2, PALB2 or Homologous Recombination Deficiency (HRD) Mutation
Prebieha náborFáza 1
- UPMC Hillman Cancer Center, Pittsburgh
Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer
Prebieha náborFáza 4
- Univ of Pittsburgh Medical Center, Pittsburgh
TERPS Trial for de Novo Oligometastic Prostate Cancer
Prebieha náborFáza 2
- UPMC Hillman Cancer Center, Pittsburgh
Androgen Suppression Combined With Nodal Irradiation and Dose Escalated Prostate Treatment
Prebieha náborFáza 3
- Allegheny General Hospital, Pittsburgh
- West Penn Hospital, Pittsburgh
- Jefferson Hospital, Jefferson Hills · 11 míľ odtiaľ
- a 2 ďalších
The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
Prebieha náborObservačná štúdia
- Allegheny Health Network, Pittsburgh
Circulating Tumor DNA in High Risk Localized Prostate Cancer
Prebieha náborObservačná štúdia
- UPMC Hillman Cancer Center, Pittsburgh
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
Prebieha náborFáza 3
- University of Pittsburgh Cancer Institute (UPCI), Pittsburgh
- UPMC-Shadyside Hospital, Pittsburgh
Štúdie Rakovina prostaty v iných mestách
- New York City, NY103 štúdií
- Houston, TX76 štúdií
- Los Angeles, CA61 štúdií
- Boston, MA59 štúdií
- St. Louis, MO46 štúdií
- Chicago, IL45 štúdií
- San Francisco, CA45 štúdií
- Philadelphia, PA44 štúdií
- Baltimore, MD43 štúdií
- Nashville, TN42 štúdií
- Seattle, WA42 štúdií
- Washington, DC38 štúdií
Iné štúdie v Pittsburgh
- Nemalobunkový karcinóm pľúc48 štúdií
- Rakovina (všetky typy)41 štúdií
- Rakovina prsníka39 štúdií
- Kolorektálny karcinóm32 štúdií
- Metastatická rakovina31 štúdií
- Melanóm31 štúdií
- Rakovina vaječníkov30 štúdií
- Rakovina endometria23 štúdií
- Rakovina pľúc23 štúdií
- Cievna mozgová príhoda22 štúdií
- Skvamóznocelulárny karcinóm hlavy a krku22 štúdií
- Depresia22 štúdií
Z ClinicalTrials.gov, dáta načítané 5. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.